TD Cowen Maintains Shattuck Labs(STTK.US) With Buy Rating
TD Cowen Maintains Shattuck Labs(STTK.US) With Buy Rating
Shattuck Labs Analyst Ratings
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Hold Rating
Needham Maintains Shattuck Labs(STTK.US) With Hold Rating
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Shattuck Labs (STTK) and Astria Therapeutics (ATXS)
Citi Downgrades Shattuck Labs(STTK.US) to Hold Rating, Cuts Target Price to $2
Evercore Maintains Shattuck Labs(STTK.US) With Buy Rating
A Quick Look at Today's Ratings for Shattuck Labs(STTK.US), With a Forecast Between $2 to $2
Citigroup Downgrades Shattuck Labs to Neutral From Buy, Adjusts Price Target to $2 From $8
Shattuck Labs Price Target Maintained With a $8.00/Share by Needham
Shattuck Labs Analyst Ratings
Shattuck Labs (STTK) Was Downgraded to a Hold Rating at H.C. Wainwright
H.C. Wainwright Maintains Shattuck Labs(STTK.US) With Buy Rating, Maintains Target Price $16
Shattuck Labs Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Citi Maintains Shattuck Labs(STTK.US) With Buy Rating, Cuts Target Price to $8
Shattuck Labs Analyst Ratings
TD Cowen Maintains Shattuck Labs(STTK.US) With Buy Rating
Buy Rating Affirmed for Shattuck Labs Amidst Promising Therapeutic Advancements and Robust Clinical Trials
Shattuck Labs Analyst Ratings